Bezafibrate prevents aging in in vitro-matured porcine oocytes
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Bezafibrate, a fibrate drug used as a lipid-lowering agent to treat hyperlipidemia, is a pan-agonist of peroxisome proliferator-activated receptor alpha. It can enhance mitochondrial fatty acid oxidation, oxidative phosphorylation, and mitochondrial biogenesis. After ovulation, oocytes may get arrested at the metaphase II (MII) stage until fertilization beyond optimal timing, which is termed as post-ovulatory aging. Post-ovulatory aging is a disease that degrades DNA, mitochondria, and oxidative system, and has a negative impact on embryo development and quality; however, the impact of bezafibrate during post-ovulatory aging has not been fully defined. In the present study, we assessed the ability of bezafibrate to prevent the progression of aging in in vitro conditions as well as the underlying mechanisms in pigs. An appropriate concentration of this drug (50 μM) was added, and then oxidative stress, reactive oxygen species downstream, mitochondrial biogenesis, and mitochondrial function were analyzed via immunofluorescence staining and real-time polymerase chain reaction. Bezafibrate significantly alleviated reactive oxygen species and ameliorated glutathione production simultaneously in oocytes and embryos. Moreover, it diminished H2A.X and attenuated CASPASE 3 expression produced by oxidative stress in oocytes and embryos. Furthermore, bezafibrate remarkably improved the mitochondrial function and blastocyst quality as well as markedly reduced the mitochondria/TOM20 ratio and mtDNA copy number. The elevated PARKIN level indicated that mitophagy was induced by bezafibrate treatment after post-ovulatory aging. Collectively, these results suggest that bezafibrate beneficially affects against porcine post-ovulatory oocyte aging in porcine by its antioxidant property and mitochondrial protection.
Abstract
Bezafibrate, a fibrate drug used as a lipid-lowering agent to treat hyperlipidemia, is a pan-agonist of peroxisome proliferator-activated receptor alpha. It can enhance mitochondrial fatty acid oxidation, oxidative phosphorylation, and mitochondrial biogenesis. After ovulation, oocytes may get arrested at the metaphase II (MII) stage until fertilization beyond optimal timing, which is termed as post-ovulatory aging. Post-ovulatory aging is a disease that degrades DNA, mitochondria, and oxidative system, and has a negative impact on embryo development and quality; however, the impact of bezafibrate during post-ovulatory aging has not been fully defined. In the present study, we assessed the ability of bezafibrate to prevent the progression of aging in in vitro conditions as well as the underlying mechanisms in pigs. An appropriate concentration of this drug (50 μM) was added, and then oxidative stress, reactive oxygen species downstream, mitochondrial biogenesis, and mitochondrial function were analyzed via immunofluorescence staining and real-time polymerase chain reaction. Bezafibrate significantly alleviated reactive oxygen species and ameliorated glutathione production simultaneously in oocytes and embryos. Moreover, it diminished H2A.X and attenuated CASPASE 3 expression produced by oxidative stress in oocytes and embryos. Furthermore, bezafibrate remarkably improved the mitochondrial function and blastocyst quality as well as markedly reduced the mitochondria/TOM20 ratio and mtDNA copy number. The elevated PARKIN level indicated that mitophagy was induced by bezafibrate treatment after post-ovulatory aging. Collectively, these results suggest that bezafibrate beneficially affects against porcine post-ovulatory oocyte aging in porcine by its antioxidant property and mitochondrial protection.
참고문헌 (31)
- Anima Tripathi, "Meiotic cell cycle arrest in mammalian oocytes", Journal of Cellular Physiology, 223, pp.592~600 (2010), Wiley[DOI]
- Qing-Yuan Sun, "Towards a new understanding on the regulation of mammalian oocyte meiosis resumption", Cell Cycle, 8(17), pp.2741~2747 (2009), Informa UK Limited[DOI]
- Tessa Lord, "Oxidative stress and ageing of the post-ovulatory oocyte", REPRODUCTION, 146(6), pp.R217~R227 (2013), Bioscientifica[DOI]
- A. L. Mikkelsen, "Morphology of in-vitro matured oocytes: impact on fertility potential and embryo quality", Human Reproduction, 16(8), pp.1714~1718 (2001), Oxford University Press (OUP)[DOI]
- Maggie M.-Y. Chi, "Contrast in Levels of Metabolic Enzymes in Human and Mouse Ova1", Biology of Reproduction, 39(2), pp.295~307 (1988), Oxford University Press (OUP)[DOI]
- Toshifumi Takahashi, "Impact of oxidative stress in aged mouse oocytes on calcium oscillations at fertilization", Molecular Reproduction and Development, 66(2), pp.143~152 (2003), Wiley[DOI]
- Tessa Lord, "Melatonin Prevents Postovulatory Oocyte Aging in the Mouse and Extends the Window for Optimal Fertilization In Vitro1", Biology of Reproduction, 88(3), pp.67~ (2013), Oxford University Press (OUP)[DOI]
- Y. Fujino, "Ovary and ovulation: DNA fragmentation of oocytes in aged mice", Human Reproduction, 11(7), pp.1480~1483 (1996), Oxford University Press (OUP)[DOI]
- Y. Takai, "Caspase-12 compensates for lack of caspase-2 and caspase-3 in female germ cells", Apoptosis, 12(4), pp.791~800 (2007), Springer Science and Business Media LLC[DOI]
- Yilong Miao, "Postovulatory aging causes the deterioration of porcine oocytes via induction of oxidative stress", The FASEB Journal, 32(3), pp.1328~1337 (2018), Wiley[DOI]
- K. Yanagida, "Influence of oocyte preincubation time on fertilization after intracytoplasmic sperm injection", Human Reproduction, 13(8), pp.2223~2226 (1998), Oxford University Press (OUP)[DOI]
- M. K. Shigenaga, "Oxidative damage and mitochondrial decay in aging", Proceedings of the National Academy of Sciences, 91(23), pp.10771~10778 (1994), Proceedings of the National Academy of Sciences[DOI]
- Maureen Redza-Dutordoir, "Activation of apoptosis signalling pathways by reactive oxygen species", Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1863(12), pp.2977~2992 (2016), Elsevier BV[DOI]
- J. Cliff Yoon, "Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1", Nature, 413(6852), pp.131~138 (2001), Springer Science and Business Media LLC[DOI]
- Nataša Nikolić, "Overexpression of PGC-1α Increases Fatty Acid Oxidative Capacity of Human Skeletal Muscle Cells", Biochemistry Research International, 2012, pp.714074~ (2012), Hindawi Limited[DOI]
- Valerie S. LeBleu, "PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis", Nature Cell Biology, 16(10), pp.992~1003 (2014), Springer Science and Business Media LLC[DOI]
- Ashu Johri, "Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's disease", Human Molecular Genetics, 21(5), pp.1124~1137 (2012), Oxford University Press (OUP)[DOI]
- S Baldelli, "PGC-1α buffers ROS-mediated removal of mitochondria during myogenesis", Cell Death & Disease, 5(11), pp.e1515~e1515 (2014), Springer Science and Business Media LLC[DOI]
- Koji YOSHIOKA, "Defined System for In Vitro Production of Porcine Embryos Using a Single Basic Medium", Journal of Reproduction and Development, 54(3), pp.208~213 (2008), Japanese Society of Animal Reproduction[DOI]
- Jean-Paul Bonnefont, "Bezafibrate for an Inborn Mitochondrial Beta-Oxidation Defect", New England Journal of Medicine, 360(8), pp.838~840 (2009), Massachusetts Medical Society[DOI]
- Hannah Steele, "Metabolic effects of bezafibrate in mitochondrial disease", EMBO Molecular Medicine, 12(3), pp.e11589~ (2020), EMBO[DOI]
- Hiroyuki Sasaki, "Impact of Oxidative Stress on Age-Associated Decline in Oocyte Developmental Competence", Frontiers in Endocrinology, 10, pp.811~ (2019), Frontiers Media SA[DOI]
- Hideki Igarashi, "Oocyte aging underlies female reproductive aging: biological mechanisms and therapeutic strategies", Reproductive Medicine and Biology, 14(4), pp.159~169 (2015), Wiley[DOI]
- Mateus Grings, "Bezafibrate prevents mitochondrial dysfunction, antioxidant system disturbance, glial reactivity and neuronal damage induced by sulfite administration in striatum of rats: Implications for a possible therapeutic strategy for sulfite oxidase deficiency", Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1863(9), pp.2135~2148 (2017), Elsevier BV[DOI]
- Ashok Agarwal, "Role of oxidative stress in female reproduction", Reproductive Biology and Endocrinology, 3(1), pp.28~ (2005), Springer Science and Business Media LLC[DOI]
- Julie St-Pierre, "Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators", Cell, 127(2), pp.397~408 (2006), Elsevier BV[DOI]
- Julie St-Pierre, "Bioenergetic Analysis of Peroxisome Proliferator-activated Receptor γ Coactivators 1α and 1β (PGC-1α and PGC-1β) in Muscle Cells", Journal of Biological Chemistry, 278(29), pp.26597~26603 (2003), Elsevier BV[DOI]
- Gustavo Nardini Cecchino, "The role of mitochondrial activity in female fertility and assisted reproductive technologies: overview and current insights", Reproductive BioMedicine Online, 36(6), pp.686~697 (2018), Elsevier BV[DOI]
- José R. Blesa, "NRF-2 transcription factor is required for human TOMM20 gene expression", Gene, 391(1-2), pp.198~208 (2007), Elsevier BV[DOI]
- Derek P. Narendra, "Targeting Mitochondrial Dysfunction: Role for PINK1 and Parkin in Mitochondrial Quality Control", Antioxidants & Redox Signaling, 14(10), pp.1929~1938 (2011), Mary Ann Liebert Inc[DOI]
- 박상희, "TOMM20 as a potential therapeutic target of colorectal cancer", BMB Reports, 52(12), pp.712~717 (2019), 생화학분자생물학회[DOI]